Chen, D., Wei, H., Zhang, Y. et al. Identification of two novel B-cell epitopes targeting the hemagglutinin protein of H9N2 avian influenza virus. Animal Diseases 6, 47 (2026)
H9N2 avian influenza virus (AIV) remains a global threat to poultry health and has zoonotic potential. Antigenic drift in the hemagglutinin (HA) protein complicates vaccine efficacy and diagnostic accuracy, highlighting the need for precise epitope characterization. In this study, the HA protein of H9N2 AIV was expressed in a eukaryotic system, and two monoclonal antibodies (mAbs), 9C12 and 9F4, were generated. Both mAbs specifically bound HA, as shown by ELISA, Western blot, and immunofluorescence, but lacked hemagglutination inhibition activity. Epitope mapping revealed two minimal linear epitopes: 123FSSSRSYQ130 within the vestigial esterase domain and 201NLYTRTDTT209 within the receptor-binding domain. Alanine scanning revealed key residues required for antibody binding, whereas structural modeling confirmed that both epitopes are surface exposed. Sequence analysis demonstrated strong conservation across H9N2 strains, with the 9F4 epitope showing near-complete invariance, whereas both epitopes exhibited low conservation among other influenza A virus subtypes. These findings define two novel, nonneutralizing epitopes on H9N2 HA that expand the antigenic map and represent promising targets for subtype-specific diagnostic assays.
See Also:
Latest articles in those days:
- Avian Influenza Weekly Update # 1062: 18 September 2026 9 hours ago
- Effectiveness of the 2025-2026 seasonal influenza vaccine among U.S. veterans: an observational study 11 hours ago
- Streamlined CRISPR-based assays for detection and subtyping of H5 and H7 avian influenza 2 days ago
- Host-specific effects of a pandemic H1N1 M gene on canine H3N2 influenza virus replication and immune responses 2 days ago
- Rapid Decline of Nesting Peregrine Falcons in the San Francisco Bay Region of California Synchronous with an Outbreak of H5N1 Highly Pathogenic Avian Influenza 2 days ago
[Go Top] [Close Window]


